Debiopharm International is a highly focused company that develops drugs and therapies with a view to bringing novel biopharmaceuticals to market. The business strategy is to create partnerships for the in-licensing of biologics and small molecules from biotechnology and pharmaceutical companies as well as academic institutions worldwide.
Lead the Pharmaceutical Development department to ensure the development and manufacturing of products tailored to the needs of patients

Presentation Title: Antibody Drug Conjugates: Panorama, perspectives and manufacturing challenges

View company profile